DECIPHERA PHARMACEUTICALS IN - COM (DCPH)

Historical Portfolio Holders from Q3 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
57.9 M
Holdings value Q1 2024
$911 M
Value change Q1 2024
+$37.6 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
166
Number of buys Q1 2024
87
Number of sells Q1 2024
-64
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
24344T101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 57.9 M $911 M +$37.6 M $15.73 166
2023 Q4 55.6 M $896 M +$23.3 M $16.13 159
2023 Q3 56.2 M $715 M +$2.59 M $12.72 151
2023 Q2 55.4 M $780 M -$31.3 M $14.08 139
2023 Q1 57.9 M $894 M +$84.8 M $15.45 144
2022 Q4 52.2 M $855 M +$1 M $16.39 138
2022 Q3 48.9 M $905 M +$20.8 M $18.50 147
2022 Q2 47.6 M $626 M +$66.5 M $13.15 113
2022 Q1 38.6 M $358 M -$33 M $9.27 109
2021 Q4 45.7 M $447 M -$377 M $9.77 131
2021 Q3 42.6 M $1.45 B -$29.2 M $33.98 157
2021 Q2 41.7 M $1.53 B -$28.9 M $36.61 139
2021 Q1 43.2 M $1.94 B -$8.56 M $44.84 161
2020 Q4 42.6 M $2.43 B +$33.7 M $57.07 178
2020 Q3 38.8 M $1.99 B -$2.79 M $51.30 153
2020 Q2 42.3 M $2.49 B +$114 M $59.72 161
2020 Q1 40.6 M $1.67 B +$192 M $41.17 139
2019 Q4 35.2 M $2.19 B +$23.9 M $62.24 147
2019 Q3 35.4 M $1.2 B +$426 M $33.94 118
2019 Q2 23.1 M $522 M +$15.7 M $22.55 84
2019 Q1 22.5 M $522 M +$15 M $23.21 79
2018 Q4 21.9 M $460 M -$21 M $20.99 77
2018 Q3 21.2 M $820 M +$22.9 M $38.72 87
2018 Q2 20.8 M $813 M +$202 M $39.35 88
2018 Q1 15.6 M $313 M -$5.21 M $20.04 53
2017 Q4 15.7 M $355 M +$34.3 M $22.67 58
2017 Q3 14.6 M $272 M +$272 M $18.99 50